NeurAxis, Inc.
AMEX:NRXSBiotechnology
+$0.29 today
- Market cap
- $69.12M
- Beta
- 1.41
- P/E (TTM)
- -10.5
- EPS (TTM)
- -$0.67
Volume 0.23M
Average 0.18M
NRXS Stock-Based Compensation
Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.
NeurAxis, Inc.AMEX: NRXS
Stock-Based Compensation · Q1 FY2026 · quarter ended Mar 2026
Stock-based compensation growth accelerates
Q1 FY2026 stock-based compensation of $329.43K rose 211.3% year over year, ahead of the -33.5% change in trailing-twelve-month stock-based compensation. Sequentially, it rose 109.6% from the prior quarter. Over 3 fiscal years it compounded at +179.6% a year.
Context
- Stock-based compensation amounted to 16.7% of revenue in FY2025, down 35.6 pp from a year earlier.
- Stock-based compensation increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +211.3% holds above the trailing-twelve-month pace of -33.5%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Stock-Based Compensation history
USD · from the cash flow
- Latest · FY2025
- 596.85K USD
- Year-over-year change
- -57.5%
- 4-year CAGR
- +87.2%
| Period | Period end | Stock-Based Compensation | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 596.85K | -57.5% |
| FY2024 | 2024-12-31 | 1.4M | +87.2% |
| FY2023 | 2023-12-31 | 750K | +2645.3% |
| FY2022 | 2022-12-31 | 27.32K | -43.8% |
| FY2021 | 2021-12-31 | 48.64K | — |
Stock-Based Compensation vs competitors
How NRXS compares with its peers on the latest reported figures
- NRXS's LTM Mar 2026 stock-based compensation of $819.93K is the smallest of the 4 companies compared; the peer median is $4.05M.
- Its year-over-year change of -33.5% is the 2nd highest of 3, against a peer median of -30.8%.
- Stock-based compensation amounts to 19.2% of revenue for NRXS, versus a peer median of 471.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $10.98B | — | +586.2% | — | |
| LTM Mar 2026 | $4.05M | -48.0% | -17.6% | 471.8% | |
| LTM Dec 2025 | $1.78M | -13.7% | -13.0% | — | |
NRXSNeurAxis, Inc. | LTM Mar 2026 | $819.93K | -33.5% | +179.6% | 19.2% |
| Peer median (excluding NRXS) | $4.05M | -30.8% | -13.0% | 471.8% | |
Competitors are the stored peer set for NRXS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (3.03M) | (4.78M) | (14.63M) | (8.24M) | (7.8M) |
| Depreciation & Amortization | 36.71K | 37.13K | 40.73K | 37.83K | 59.5K |
| Deferred Income Tax | 41.11K | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 48.64K | 27.32K | 750K | 1.4M | 596.85K |
| Change in Working Capital | 644.43K | 1.27M | (665.75K) | 141.4K | 610.12K |
| Accounts Receivables | 184.26K | (78.6K) | 75.95K | (178.85K) | 46.59K |
| Inventory | 67.67K | (8.95K) | 26.91K | (32.5K) | (242.87K) |
| Accounts Payables | 319.23K | 1.11M | (387.9K) | (607.27K) | (457.58K) |
| Other Working Capital | 73.28K | 249.62K | (380.71K) | 960.02K | 1.26M |
| Other Non-Cash Items | 22.81K | 1.15M | 7.81M | 559.82K | 101.24K |
| Operating Cash Flow | (2.23M) | (2.3M) | (6.69M) | (6.1M) | (6.43M) |
| Capital Expenditures | (1.39K) | (61.21K) | (71.78K) | (27.78K) | (31.15K) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | (59.82K) | (41K) | 0 | (100K) |
| Investing Cash Flow | (1.39K) | (61.21K) | (71.78K) | (27.78K) | (131.15K) |
| Debt Repayment | 151.1K | 3.16M | 2.07M | 4.66M | (281.75K) |
| Common Stock Issued | 510K | 0 | 4.85M | 0 | 8.83M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (510K) | (866.74K) | (322.9K) | (168.32K) | (712.67K) |
| Financing Cash Flow | 661.1K | 2.29M | 6.59M | 9.74M | 7.83M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | (1.57M) | (67.16K) | (175.14K) | 3.62M | 1.27M |
| Free Cash Flow | (2.24M) | (2.36M) | (6.77M) | (6.13M) | (6.46M) |
NeurAxis, Inc.
AMEX:NRXS
Intrinsic Alpha fair value
Locked
Current Price
$4.87
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.